Two Sigma Investments’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-101,690
| Closed | -$1.54M | – | 4128 |
|
|
2019
Q4 | $1.54M | Buy |
+101,690
| New | +$878K | ﹤0.01% | 1815 |
|
|
2019
Q3 | – | Sell |
-182,225
| Closed | -$1.74M | – | 3957 |
|
|
2019
Q2 | $1.74M | Buy |
182,225
+112,968
| +163% | +$1.22M | 0.01% | 1533 |
|
|
2019
Q1 | $938K | Buy |
69,257
+21,996
| +47% | +$183K | ﹤0.01% | 1870 |
|
|
2018
Q4 | $340K | Sell |
47,261
-247,394
| -84% | -$2.71M | ﹤0.01% | 2369 |
|
|
2018
Q3 | $3.21M | Sell |
294,655
-44,098
| -13% | -$445K | 0.01% | 1163 |
|
|
2018
Q2 | $3.12M | Buy |
338,753
+107,789
| +47% | +$1M | 0.01% | 1322 |
|
|
2018
Q1 | $1.84M | Buy |
+230,964
| New | +$5.03M | 0.01% | 1581 |
|
|
2017
Q2 | – | Sell |
-71,406
| Closed | -$2.44M | – | 3431 |
|
|
2017
Q1 | $2.44M | Buy |
+71,406
| New | +$2.3M | 0.01% | 1339 |
|
|
2016
Q3 | – | Sell |
-35,771
| Closed | -$1.05M | – | 3487 |
|
|
2016
Q2 | $1.05M | Buy |
+35,771
| New | +$987K | ﹤0.01% | 1698 |
|
Two Sigma Investments's DERM Position: Q1 2020 in Review
Two Sigma Investments sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 101,690 shares — an estimated $1.54M sold.
Two Sigma Investments first reported a position in DERM in Q2 2016 and held it in 9 quarters. The position peaked at $3.21M in Q3 2018. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Two Sigma Investments reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Two Sigma Investments sold 101,690 Dermira, Inc. shares in Q1 2020, an estimated $1.54M.
- Two Sigma Investments first reported a position in Dermira, Inc. in Q2 2016 and held it in 9 quarters.
- Two Sigma Investments's Dermira, Inc. position peaked at $3.21M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.